Comparison between two chlorhexidine gels for treatment of chronic periodontitis

ISRCTN ISRCTN35210084
DOI https://doi.org/10.1186/ISRCTN35210084
Secondary identifying numbers 1/2010
Submission date
30/06/2014
Registration date
31/07/2014
Last edited
17/12/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Long-term gum disease (chronic periodontitis) is the inflammation of the tissues around the teeth caused by dental plaque and calculus (tartar). The first phase of treatment usually consists of removal of irritants by a procedures such as scaling and root planing. Disinfectant substances may be additionally used during the procedure and are routinely recommended for the home care after such a procedure. The aim was to evaluate the effect of a new hydrophobic gingiva-adhering gel, in comparison with a standard commercially-available 1% chlorhexidine digluconate water-soluble gel, in non-surgical therapy of moderate long-term gum disease, after full mouth scaling and root planing.

Who can participate?
Adults aged 40-65 years, suffering from a long-term gum disease can take part.

What does the study involve?
The participants were randomly allocated to one of two groups. The test group received the hydrophobic gel for gentle rubbing on the gum (gingiva), once every second day for 14 days. The control group received the standard water-soluble chlorhexidine gel, daily, twice a day.

What are the possible benefits and risks of participating?
Enrolled participants will gain a complete non-surgical treatment of periodontitis. There were no side effects of treatment.

Where is the study run from?
1. The Victor Babes University of Medicine and Pharmacy of Timisoara (Romania)
2. Iuliu Hatieganu University of Medicine of Cluj (Romania)
3. University of Leipzig (Germany)

When is the study starting and how long is it expected to run for?
The study took place between January 2010 and May 2013.

Who is funding the study?
lege artis Pharma, Dettenhausen, Germany.

Who is the main contact?
Prof Stefan-Ioan Stratul
sbs@online.ro

Contact information

Prof Stefan Ioan Stratul
Scientific

Victor Babes University of Medicine and Pharmacy Timisoara
Faculty of Dental Medicine
Piata
Eftimie Murgu, nr 2A
Timisoara
300041
Romania

Phone +40 (0) 744 521 470
Email sbs@online.ro

Study information

Study designRandomized parallel controlled double-blind trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEvaluation of a hydrophobic gel adhering to the gingiva in comparison with a standard water soluble 1% chlorhexidine gel after full mouth scaling and root planing in patients with moderate chronic periodontitis: a randomized clinical trial
Study acronymdurimplant
Study objectivesThe study tested the null hypothesis that there are no differences in the outcomes regarding the probing depth, attachment level, plaque indices, bleeding on probing, as well as subgingival microbiota and PMN-characterizing enzymes during the first 6 months after scaling and root planing.
Ethics approval(s)1. Ethics Committees of the Faculty of Medicine of the University of Leipzig, ref. approval No.190 2009
2. Victor Babes University of Medicine and Pharmacy of Timisoara, ref. 12/14.12.2009
Health condition(s) or problem(s) studiedPeriodontitis
InterventionFull mouth scaling and root planing, application of a novel hydrophobic gingiva-adhering chlorhexidine-based gel with complex composition vs a standard commercially available 1% chlorhexidine digluconate water-soluble gel.
Intervention typeOther
Primary outcome measureClinical measurements and photographs were taken at baseline and at follow-up post-operatory 3 and 6 months for both primary and secondary outcome measures.
1. Clinical attachment level
2. Frequency of detection of periodontopathogenic bacteria
3. Enzymatic activity of neutrophil elastase and myeloperoxidase
Secondary outcome measures1. Pocket depth
2. Gingival recession
3. Plaque indices
Overall study start date01/01/2010
Completion date31/05/2013

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants32 calculated, 34 included
Total final enrolment34
Key inclusion criteria1. Age between 40 – 65 years old,
2. Moderate chronic periodontitis (two or more interproximal sites with ≥ 4 mm clinical CAL [not on the same tooth] or two or more interproximal sites with ≥ 5 mm PD, also not on the same tooth [according to the CDC-AAP definition])
3. At least 20 teeth present in the mouth
4. No periodontal therapy during the last 2 years
5. No antibiotic or anti-inflammatory drugs intake during the last 6 months before baseline examination
6. Absence of fixed or removable prosthesis
7. Good general health
Key exclusion criteria1. Either pregnant or nursing
2. Any diseases with influence on the periodontal diseases
3. Allergies to the components of the products used in the study
Date of first enrolment01/01/2010
Date of final enrolment31/05/2013

Locations

Countries of recruitment

  • Romania

Study participating centre

Victor Babes University of Medicine and Pharmacy Timisoara
Timisoara
300041
Romania

Sponsor information

lege artis Pharma GmbH + Co. KG (Germany)
Industry

Breitwasenring 1
Dettenhausen
D-72135
Germany

Website http://www.legeartis.de

Funders

Funder type

Industry

lege artis Pharma GmbH + Co. KG, Dettenhausen, Germany

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/02/2017 17/12/2020 Yes No

Editorial Notes

17/12/2020: The following changes were made to the trial record:
1. Publication reference added.
2. The total final enrolment was added.